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Abstract
Alu-PCR is a relatively simple technique that can be used to investigate genomic instability in cancer. This technique
allows identification of the loss, gain or amplification of gene sequences based on the analysis of segments between
two Alu elements coupled with quantitative and qualitative analyses of the profiles obtained from tumor samples, sur-
gicalmarginsandblood.Inthiswork,weusedAlu-PCRtoidentifygenealterationsintenpatientswithinvasiveductal
breast cancer. Several deletions and insertions were identified, indicating genomic instability in the tumor and adja-
cent normal tissue. Although not associated with specific genes, the alterations, which involved chromosomal bands
1p36.23, 1q41, 11q14.3, 13q14.2, occurred in areas of well-known genomic instability in breast and other types of
cancer. These results indicate the potential usefulness of Alu-PCR in identifying altered gene sequences in breast
cancer. However, caution is required in its application since the Alu primer can produce non-specific amplification.
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Introduction
Molecular genetic and cytogenetic analyses of breast
cancer samples suggest that the development of this type of
cancer involves the clustering of several, mainly structural,
genetic alterations (Devilee and Cornelisse, 1994; El-
Ashry and Lippmann, 1994; Beckmann et al., 1997). Point
mutations, such as small deletions and insertions, are the
most widely described mutations, although genomic rear-
rangements are also very common (Montagna et al., 2003;
Belogianni et al., 2004; Agata et al., 2005). Chromosomal
deletions and loss of heterozygosity (LOH) may indicate
the inactivation of tumor suppressor genes in the affected
region (Kenemans et al., 2004).
Oneofthemechanismsproposedtoexplaintheorigin
of deletions and insertions is based on the dispersion dy-
namics of transposable elements in the genome. According
to Presneau et al. (1998), abortive integration of a trans-
poson can be simultaneously responsible for a deletion and
an insertion. The insertion of a transposon may damage
DNA by interrupting the gene, but when unequal homolog
recombination occurs several genes can be affected, with
unpredictableconsequencestothephenotype.Indeed,there
is strong evidence of a relationship between transposable
elements and human genetic diseases. For example, inser-
tion of Alu elements appears to be involved in the etiology
of 0.1-0.3% of human genetic diseases, including Tay-
Sachsdisease,Duchennemusculardystrophy,complement
deficiency, and breast, ovary and colorectal cancer (Batzer
and Deininger, 2002; Chen et al., 2005).
Arelativelysimpletechniquethathasbeenusedtoin-
vestigate genomic instability in cancer is Alu-PCR (Tson-
galis et al., 1993; Furmaga et al., 2003, 2004) that is based
on the large number of copies of the Alu retroelement in the
human genome. Alu elements are sequences of ~300 nu-
cleotides (Cordaux et al., 2006) known as SINEs (short in-
terspersed nuclear elements), of which there are ~500,000
copies (Deininger and Batzer, 1999; Batzer and Deininger,
2002) that account for 10% of the human genome (Ng and
Xue, 2006). Deletions or insertions between two elements
areeasilydetectedbyPCR(Stroutetal.,1998;Suminagaet
al., 2000; Rowold and Herrera, 2000; Stenger et al., 2001;
Weichenrieder et al., 2001). Since Alu elements can be in-
serted in opposite directions in a DNA sequence, it is
possible to use only one primer in the PCR reaction to de-
tect genetic alterations in cancer cells (Furmaga et al.,
2003). Alu-PCR does not search for a specific locus but
yields a profile of bands of genomic DNA that may differ
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Research Articlebetween tumor and normal adjacent (control) tissues of the
same patient. The gain or loss of genomic material may in-
volve large or small gene sequences associated with LOH
and/or gene amplification.
According to Fumarga et al. (2003, 2004), Alu-PCR
isaverysensitivetechniquethathastheadvantageofbeing
able to detect novel genomic alterations without the need
for prior knowledge of these sequences. Alu-PCR has been
used to identify the genetic changes potentially involved in
lung carcinoma metastasis (Furmaga et al., 2003) and to
distinguish typical pulmonary carcinoids from classic
midgut carcinoids, which are histologically similar (Fur-
maga et al., 2004). However, there is no information about
the sequences of the altered bands that allows identifying
the segments involved in the genetic gains or losses.
The aim of this study was to investigate the genomic
instability of sporadic invasive ductal breast cancer by us-
ing Alu-PCR as an alternative approach to other methods
commonly used to obtain comparative fingerprints of can-
cerandnormaltissues,e.g.,AP-PCR(Peinadoetal.,1992),
MS-AP-PCR (Gonzalgo et al., 1997) and Inter-SSR-PCR
(Basik et al., 1997). Additionally, we sequenced the frag-
ments involved in the gains or losses in order to identify
their sequences and compared them with the human ge-
nome database.
Material and Methods
Samples
Genomic DNA was extracted from tumor and appar-
ently normal tissues, surgical margins and blood of ten pa-
tients(50-69yearsold)whounderwentsurgeryforremoval
of invasive ductal breast carcinoma with grade II or III tu-
mors. The samples were collected and the tumor grade was
classified macroscopically by medical professionals of the
Gynecological Oncology and Mastology Unit of the De-
partmentofGynecologyandObstetrics,thePlasticSurgery
Service of the Department of Surgery, and the Pathological
Anatomy Service of the Department of Pathology and Fo-
rensic Medicine of the São José do Rio Preto School of
Medicine. The material was donated after written informed
consent from all participants and its use in this project was
approved by the Ethics Committee at UNESP in São José
do Rio Preto and by the National Committee for Ethics in
Research (CONEP, registration no. 10811).
Genomic DNA extraction
Genomic DNA was extracted from fresh solid tissue
by using the DNA extraction protocol described by Sam-
brook et al. (1989).
Alu-PCR
Hot-start PCR was done with 150 ng of genomic
DNA in a reaction with a final volume of 25 L containing
1.25 U of TaqBead hot-start polymerase (Promega),
200 M of each dNTP, 1X PCR buffer, 1.5 mM MgCl2 and
100 ng of Alu initiator (5’-GGCAGACTCCATCTCAAA-
3’) that anneals at the 3’ end of the Alu element, immedi-
ately before the poly-A tail. The cycling parameters were:
initial denaturation at 94 °C for 3 min, followed by 40 cy-
cles of denaturation at 94 °C for 2 min, annealing at 55 °C
for 2 min and extension at 72 °C for 3 min. The final exten-
sion was at 72 °C for 10 min. The amplification products
were separated by electrophoresis in 7.5% polyacrylamide
gels and stained with silver nitrate (Caetano-Anollés and
Bassam, 1993). Initially, the gels were run at a constant
power of 300 V for 30 min followed by4ha taconstant
power of 100 V at room temperature. The gels were fixed
using a standard procedure and dried on cellophane and
20% glycerol, as described by Ceron et al. (1992).
Selection of candidate bands and extraction
The bands representing possible insertions, deletions
and amplifications were extracted from the dried gels and
elutedovernightat37°Cinelutionbuffer.Theelutedmate-
rialwasthencentrifugedandtheDNAwasprecipitated,de-
hydrated and eluted in 10 L of elution buffer followed by
storage at -20 °C for subsequent cloning and sequencing.
Quantitative (gain or loss of a specific band) and qua-
litative (change in band intensity) analyses of the Alu pro-
file were done by comparing the profiles of 100-700 bp
fragments obtained with this technique since bands in this
size range provided better staining and visualization. The
bands were visualized with a UV lightbox since this al-
lowedthedetectionofweaklystainedbandsthatwerediffi-
cult to see in digitalized images.
Cloning and sequencing
Fragments extracted from the polyacrylamide gels
were amplified under the same conditions as the Alu-PCR.
The products were separated on 1% agarose gels, from
which they were subsequently extracted, purified and
cloned. Two colonies in which the presence of the plasmid
with an insert was confirmed were selected and the plas-
mids were extracted using the alkaline lysis “miniprep”
method(FlexiPrepkit,Amersham),accordingtothemanu-
facturer’sinstructions.SequencingwasdoneinanABI377
sequencer and sequence consensus was determined with
the BioEdit Sequence Alignment Editor program (Hall,
1999). Sequence identification and chromosomal localiza-
tionweredeterminedbysearchingthehumangenomedata-
base with the basic local alignment tools BLAST and
BLAT.
Results
Differences in the electrophoretic band profile were
observed in 9 out of the 10 cases studied. The total number
of quantitative and qualitative alterations observed was
3.30  2.98 per patient (mean  SD Table 1), and the most
26 Fazza et al.frequently observed alteration was the loss of bands in tu-
mortissue(1.001.05alterationsperpatient).Twofigures
are provided to illustrate the results obtained. Figure 1
shows the electrophoretic profiles of the three replicates of
tumor, surgical margin and blood DNA samples from pa-
tient n. 2 and confirms the reproducibility of the results.
This figure also shows that blood contained a band that was
absent for the surgical margin and tumor samples. Figure 2
shows the electrophoretic profiles of the tumor, surgical
margin and blood DNA of patient no. 5. In this case, the tu-
mortissueshowedtwodeletions,oneof~500bp(forwhich
the corresponding band in blood was sequenced) and an-
other of ~600 bp that was only weakly visible in the digita-
lized image.
Five bands from different cases were selected for
cloning and sequencing. Table 2 summarizes the tissues
(tumor, surgical margin or blood) that were altered in five
patients and shows the band that was selected for sequenc-
ing, the type of genetic alteration (gain or loss of a se-
quence), the band size, the gene location of each altered se-
quenceandtheidentityofeachclonewithasequenceinthe
human genome. The chromosomal location of these se-
quences is shown in Figure 3. All of the sequences had a
transposable element at at least one extremity or internally,
within the sequence. The only case with Alu sequences at
both extremities, as shown by Alu-PCR, was patient 10: the
sequence had an AluSg1 sequence at the 5’ end and an
AluSg sequence at the 3’ end. In patient no. 2, the sequence
consisted of an L1PA14 element of the LINE superfamily,
followed by an AluSg sequence at the 3’ end. In patient no.
5, the sequence that was amplified belonged to an intronic
regionoftheKCNK2genethatharboredthreetransposable
elements, L1ME1, AluJo and AluSc, of which AluJo was
possibly a complete element because of its 294 bp size. Pa-
tients 3 and 9 had exactly the same altered region, with an
Alu element at the 3’ end and no other transposable ele-
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Table 1 - Quantitative and qualitative changes observed in the Alu profile.
Quantitative Qualitative Total
Sample Band gain Band loss
TU SM BL TU SM BL TU SM BL
Patient 1 1 1 0 0 0 0 0002
Patient 2 0 0 0 3 2 0 0005
Patient 3 3 3 0 2 0 0 1009
Patient 4 0 1 0 1 1 0 2106
Patient 5 1 0 0 2 2 0 1006
Patient 6 0 0 0 1 0 0 0001
Patient 7 0 0 0 0 0 0 0000
Patient 8 0 0 0 1 0 0 0001
Patient 9 0 0 0 0 0 0 1001
Patient 10 0 0 0 0 0 0 1102
Mean  SD 0.50  0.97 0.50  0.97 0 1.00  1.05 0.50  0.85 0 0.60  0.69 0.20  0.42 0 3.30  2.98
BL – blood, SM – surgical margin, TU – tumor.
Figure 1 - Electrophoretic profiles of three replicates of tumor (TU), sur-
gical margin (SM) and blood (BL) DNA samples from patient no. 2 show-
ing the reproducibility of the Alu-PCR profile in breast cancer. The arrow
indicatesabandpresentinthebloodsamplethatislessvisibleinthesurgi-
cal margin and absent in tumor tissue.
Figure 2 - Electrophoretic profiles of tumor (TU), surgical margin (SM)
andblood(BL)DNAsamplesfrompatientno.5.Notethepresenceoftwo
deletions in the tumor tissue, one of ~500 bp (sequenced from the corre-
sponding band extracted from the blood sample, indicated by the asterisk)
and another of ~600 bp (this band was fainter in the digitalized image).ments at the 5’ end. Although they shared the same altered
region, patient 3 presented a sequence gain and patient 9 a
sequence loss.
Figure 4 shows the non-specific alignments between
the Alu primer and the LINE elements found in the se-
quenced fragment of patients 2 (L1PA14)a n d5( L1ME1)
and in the flanking region without an Alu element in pa-
tients3and9.Ascanbeseen,10-13ofthe18nucleotidesof
the Alu primer occurred in the 3’ end of the L1PA14 and
L1ME1 elements or in the intergenic flanking region. The
high similarity (55%-72%) between the sequences of these
regions and the Alu primer apparently accounted for the
non-specific amplifications.
Discussion
Genomic instability accompanies the progression of
neoplasia and probably predisposes the individual to addi-
tional genetic alterations that confer proliferative advan-
tages to the cells. The sequence between two Alu elements
may be more susceptible to deletions and unequal recom-
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Table 2 - Sequencing results for the candidate bands.
Patient Altered tissue Band alteration Tissue analyzed Band size Genomic localization (position) Identity (%)
2 TU and SM Loss BL 300-400 bp 11q14.3 (89867448-89868025) 98.7
2 TU and SM Loss BL 300-400 bp 11q14.3 (89867448-89868009) 99.3
3 TU and SM Gain TU and SM 400-500 bp 1p36.23 (8828760-8829352) 96.8
3 TU and SM Gain TU and SM 400-500 bp 1p36.23 (8828760-8829328) 98.0
5 TU Loss BL and SM 500 bp 1q41 (213251146-213251604) 99.8
5 TU Loss BL and SM 500 bp 1q41 (213251146-213251604) 99.8
9 TU and SM Loss BL 300-400 bp 1p36.23 (8828760-8829350) 98.6
9 TU and SM Loss BL 300-400 bp 1p36.23 (8828760-8829354) 98.7
10 TU and SM Gain TU and SM 500 bp 13q14.2 (47667917-47668511) 98.9
10 TU and SM Gain TU and SM 500 bp 13q14.2 (47667917-47668496) 99.1
BL – blood, SM – surgical margin, TU – tumor.
Figure 3 - Schematic representation of the chromosomal position of each sequence extracted from the gels. The black boxes indicate the sequences that
were analyzed, the empty boxes below each sequence represent transposable elements, and the gray boxes represent exons of the KCNK2 gene.
Figure4-AlignmentbetweentheAluprimerusedfortheAlu-PCRtechniqueandtheLINEelementsfoundinthebandsofpatients2and5andtheflank-
ing region without an Alu element found in patients 3 and 9.binations and, consequently, to the formation of new rear-
rangements. This hypothesis is supported by Batzer and
Deininger (2002) who stated that the high density of Alu el-
ements in human DNA provides “hot spots” for homolog
recombination and chromosomal translocation.
In the present work, genomic DNA from tumor tis-
sue, surgical margins and blood from ten patients who un-
derwent surgery for the removal of invasive ductal breast
carcinoma was analyzed with Alu-PCR. The most fre-
quently observed alteration in tumor tissue was the loss of
fragments, with an average loss of one band for every 3.3
altered bands. This value was approximately twice that of
the gain of new bands, on average 0.6 per patient for the
sametissue.Surgicalmarginsalsoshowedalterationsinthe
Alu-PCR profile, with frequencies of 0.5  0.97 new bands
and 0.5  0.85 lost bands per patient This result may reflect
the presence of tumor cells that are not detectable by the
routine histopathological examination of surgical margins
(Cesar et al., 2004, 2006; Hughes et al., 2006). Similarly,
qualitative alterations in tumor tissue may be caused by the
presence of normal stroma cells or leukocytes.
The sequences corresponding to the altered bands
(1p36.23, 1q41, 11q14.3 and 13q14.2) belonged to regions
associated with genomic instability and cancer. The loss of
genetic material in chromosome 1p has been observed in
many types of cancer, and is particularly frequent in breast,
lung, endometrium and ovary cancer and in gliomas (Bar-
bashina et al., 2005). The loss of heterozygosity suggested
the presence of one (Ragnarsson et al., 1999) or several
(Barbashina et al., 2005) tumor suppressor genes in this
chromosomal arm.
Studies of different human neoplasias, including
breast cancer, teratoma, astrocyte glioma, osteosarcoma,
hepatocellular carcinoma and prostate cancer, have sug-
gested the presence of a tumor suppressor gene in the long
arm of chromosome 1 (Ding, 1992; Mertens, 1993; Murty
et al., 1994; Li et al., 1995; Loupart et al., 1995; Berthon et
al.,1998).InBLASTanalysis,thesequenceat1q41waslo-
catedinanintronicregionoftheKCNK2genewhichcoded
for a member of the two-pore-domain background potas-
sium channel protein family. Another member of this fam-
ily, TASK3 or KCNK9, was also amplified and showed
elevated expression in breast tumors. Elevated expression
ofTASK3incelllinesconfersresistancetohypoxiaandse-
rum deprivation, suggesting an important physiological
role for this gene in breast tumorigenesis (Mu et al., 2003).
The loss of 500 bp by the KCNK2 gene deserves further
studies since intron alterations can affect internal promoter
or splicing sites, thereby changing gene expression.
A loss of heterozygosity in the 11q14.3 region has
been observed in head and neck cancer and correlated with
tumorgrade(Glavacetal.,2003).Inbreastcancercelllines
studied by comparative genomic hybridization (CGH) and
spectralkaryotyping(SKY)theregionsmostcommonlyaf-
fected by LOH included 11q14-qter (Kytola et al., 2000).
The region 13q14 contains genes related to a variety of
neoplasias,suchasRB1,whichhoweverislocatedinaseg-
ment distant from the sequence analyzed. Some expressed
sequence tags (DB448514, CD359283 and DB445670)
have been mapped to the segment that comprises the se-
quenced clone, and the nearest gene is LCP1 of the plastin
family of actin-bundling proteins. Foran et al. (2006) ob-
served elevated expression of L-plastin associated with in-
creasedproliferationandinvasionandlossofE-cadherinin
a colorectal cancer cell line and suggested that this protein
played an important role in metastasis.
Alu-PCRidentifiedstructuralgeneticalterationssuch
as deletions and insertions and provided a profile of quanti-
tative and qualitative changes in the samples studied here.
These rearrangements were expected to be flanked by two
Alu elements. The sequences showed three patterns in the
fivepatients.Theexpectedpatternwasobservedonlyinpa-
tient10,withAluSg1andAluSgflankingtheinsertionintu-
morandmarginaltissues.Ontheotherhand,patients2,3,5
and 9 had Alu at the 3’ end but not at the 5’ end. Patients 2
and 5 harbored the retroposon L1 (L1PA14 and L1ME1).
L1 elements are long interspersed nuclear elements
(LINES) associated with insertion mutations and chromo-
somal rearrangements that have been correlated with sev-
eral human diseases, including breast cancer (Ostertag and
KazazianJr,2001).Patients3and9sharedthesamealtered
sequence with no transposable element at the 5’ end. The
amplificationofthesenon-Alusequencesprobablyresulted
from the lack of absolute specificity of the Alu primer at its
3’ end. Non-specific annealing consistently occurred at the
5’ end of the fragment, but we have no explanation for this
selectivity.
Alu-PCR was originally designed to identify rear-
rangementsmediatedbyAlus.However,asshownhere,the
Alu-primer amplified other sequences in addition to those
flanked by Alus. Since L1 is a major source of non-specific
genetic instability in humans the amplification also reveals
genetic instability and do not compromise the efficiency of
thetechnique.Ourfindingsshowthatcautionmustbeexer-
cised when using this technique because of the risk of
obtaining a spurious amplification, as observed for the
1p36.23 region. Nevertheless, these spuriously amplified
sequences are interesting because they may be involved in
genetic rearrangements that include a gain or loss of frag-
ments of DNA. Thus, Alu-PCR can be helpful as a prelimi-
nary strategy for screening regions of genomic instability
involved in the initiation and progression of cancer and
other diseases. The identification of unstable segments can
function as potential biomarkers for the early detection of
tumors and may be of prognostic use in monitoring disease
progression.
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